Pijnenburg, Lisa J.
Velikonja, Tjasa
Pietrzak, Robert H.
DePierro, Jonathan
de Haan, Lieuwe
Todd, Andrew C.
Dasaro, Christopher R.
Feder, Adriana
Velthorst, Eva
Article History
Received: 20 September 2022
Accepted: 28 September 2023
First Online: 24 October 2023
Declarations
:
: Dr. Feder is named co-inventor on an issued patent in the United States and several issued patents outside of the United States, filed by the Icahn School of Medicine at Mount Sinai for the use of ketamine as therapy for posttraumatic stress disorder; this intellectual property has not been licensed.
: The investigation was carried out in accordance with the latest version of the Declaration of Helsinki, the study design was reviewed and approved by the Mount Sinai Institutional Review Board.